Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004556 · ClinicalTrials.gov registry record
The Effects of Dextroamphetamine on Brain Function
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 108
- Enrollment target
NCT00004556 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 108 participants.
The verdict
NCT00004556 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of the drug dextroamphetamine on the brain function and mood of healthy volunteers. Monoaminergic drugs are substances that affect the nervous system; these drugs can raise, hamper, or have no effect on brain function when given to healthy individuals. Different responses to a drug may be the result of genetic variations. This study will examine the effects of the monoaminergic drug dextroamphetamine on thought and sensorimotor processes while participants perform a variety of tasks. Participants in this study will undergo a medical history, physical examination, blood tests, and an electrocardiogram (EKG). Women of reproductive potential will undergo a pregnancy test. Participants will be given either dextroamphetamine or placebo (an inactive solution) on two occasions separated by at least 3 to 7 days. Participants will then perform neuropsychological tests that will measure attention, problem solving, memory, and ability to complete simple motor tasks.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 1991-09-30 |
| Est. Completion | 2018-09-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004556
The ClinicalTrials.gov registry entry for NCT00004556 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00004556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004556 about?
NCT00004556 is a clinical study titled "The Effects of Dextroamphetamine on Brain Function". The purpose of this study is to determine the effects of the drug dextroamphetamine on the brain function and mood of healthy volunteers. Monoaminergic drugs are substances that affect the nervous system; these drugs can raise, hamper, or have no effect on brain function when given to healthy indiv...
What is the current status of trial NCT00004556?
This trial is currently completed. The enrollment target is 108 participants. The study started on 1991-09-30. Estimated completion is 2018-09-25.
Who is sponsoring clinical trial NCT00004556?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.